Xolair (omalizumab) - Roche, Novartis
Omalizumab and food allergy: does reaction severity improve in adult patients? (PubMed, Postepy Dermatol Alergol) - Oct 18, 2026 - "Omalizumab treatment was associated with a consistent reduction in the severity of food-related allergic reactions upon re-exposure in adults with CSU and IgE-mediated food allergy. Clinical improvement occurred largely independently of conventional allergic biomarkers." 
Journal • Allergy • Chronic Spontaneous Urticaria • Dermatology • Food Hypersensitivity • Immunology • Urticaria • CRP
http://www.ncbi.nlm.nih.gov/pubmed/42889680
 
Zeynep Yegin Katran
 
Oct 18, 2026
 
Prev Next